APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Disease Drugs Market Analysis and Forecast 2026-2032

22 December 2025210 pages

Choose your research edition.

Industry ResearchPet Disease Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pet Disease Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pet Disease Drugs include Zoetis, Merck & Co., Inc., Zuche Pharmaceuticals, Virbac, Vetoquinol S.A., VETINDIA Pharmaceuticals, SOUND Technologies, SeQuent Scientific and Richter Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pet Disease Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Disease Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pet Disease Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Disease Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Disease Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pet Disease Drugs sales, projected growth trends, production technology, application and end-user industry.

Pet Disease Drugs Segment by Company

Zoetis

Merck & Co., Inc.

Zuche Pharmaceuticals

Virbac

Vetoquinol S.A.

VETINDIA Pharmaceuticals

SOUND Technologies

SeQuent Scientific

Richter Pharma

Ourofino Animal Health

Norbrook Laboratories

Multi Radiance Medical

Morvel Laboratories

LABINDIA Healthcare

K-Laser USA

IRM Enterprises

Fidelis Animal Health

Elanco Animal Health

Dechra Pharmaceuticals

Chanelle Pharma

Ceva

Century Pharmaceuticals

Calier

Boehringer Ingelheim

Bimeda

Avazzia

Assisi Animal Health

Ashish Life Science

Pet Disease Drugs Segment by Type

Analgesics

Anti-inflammatory

Parasiticides

Anti-infectives

Others

Pet Disease Drugs Segment by Application

Behavioral Diseases

Pain

Dermatologic Diseases

Orthopedic Diseases

Infectious Diseases

Other

Pet Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pet Disease Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Disease Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Disease Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Analgesics Major Manufacturers Table 3. Anti-inflammatory Major Manufacturers Table 4. Parasiticides Major Manufacturers Table 5. Anti-infectives Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Pet Disease Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Behavioral Diseases Major Manufacturers Table 9. Pain Major Manufacturers Table 10. Dermatologic Diseases Major Manufacturers Table 11. Orthopedic Diseases Major Manufacturers Table 12. Infectious Diseases Major Manufacturers Table 13. Other Major Manufacturers Table 14. Pet Disease Drugs Industry Trends Table 15. Pet Disease Drugs Industry Drivers Table 16. Pet Disease Drugs Industry Opportunities and Challenges Table 17. Pet Disease Drugs Industry Restraints Table 18. Global Pet Disease Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pet Disease Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Pet Disease Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Pet Disease Drugs Revenue Market Share by Region (2021-2026) Table 22. Global Pet Disease Drugs Revenue Market Share by Region (2027-2032) Table 23. Global Pet Disease Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global Pet Disease Drugs Sales by Region (2021-2026) & (k units) Table 25. Global Pet Disease Drugs Sales by Region (2027-2032) & (k units) Table 26. Global Pet Disease Drugs Sales Market Share by Region (2021-2026) Table 27. Global Pet Disease Drugs Sales Market Share by Region (2027-2032) Table 28. Global Pet Disease Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Pet Disease Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Pet Disease Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Pet Disease Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global Pet Disease Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 33. Global Pet Disease Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pet Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Pet Disease Drugs Manufacturers, Product Type & Application Table 36. Global Pet Disease Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Pet Disease Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pet Disease Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Pet Disease Drugs Revenue Market Share by Type (2021-2026) Table 43. Global Pet Disease Drugs Revenue Market Share by Type (2027-2032) Table 44. Global Pet Disease Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 46. Global Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 47. Global Pet Disease Drugs Sales Market Share by Type (2021-2026) Table 48. Global Pet Disease Drugs Sales Market Share by Type (2027-2032) Table 49. Global Pet Disease Drugs Price by Type (2021-2026) & (US$/unit) Table 50. Global Pet Disease Drugs Price by Type (2027-2032) & (US$/unit) Table 51. Global Pet Disease Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Pet Disease Drugs Revenue Market Share by Application (2021-2026) Table 55. Global Pet Disease Drugs Revenue Market Share by Application (2027-2032) Table 56. Global Pet Disease Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 58. Global Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Pet Disease Drugs Sales Market Share by Application (2021-2026) Table 60. Global Pet Disease Drugs Sales Market Share by Application (2027-2032) Table 61. Global Pet Disease Drugs Price by Application (2021-2026) & (US$/unit) Table 62. Global Pet Disease Drugs Price by Application (2027-2032) & (US$/unit) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Zoetis Pet Disease Drugs Product Portfolio Table 67. Zoetis Recent Development Table 68. Merck & Co., Inc. Company Information Table 69. Merck & Co., Inc. Business Overview Table 70. Merck & Co., Inc. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck & Co., Inc. Pet Disease Drugs Product Portfolio Table 72. Merck & Co., Inc. Recent Development Table 73. Zuche Pharmaceuticals Company Information Table 74. Zuche Pharmaceuticals Business Overview Table 75. Zuche Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio Table 77. Zuche Pharmaceuticals Recent Development Table 78. Virbac Company Information Table 79. Virbac Business Overview Table 80. Virbac Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Virbac Pet Disease Drugs Product Portfolio Table 82. Virbac Recent Development Table 83. Vetoquinol S.A. Company Information Table 84. Vetoquinol S.A. Business Overview Table 85. Vetoquinol S.A. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Vetoquinol S.A. Pet Disease Drugs Product Portfolio Table 87. Vetoquinol S.A. Recent Development Table 88. VETINDIA Pharmaceuticals Company Information Table 89. VETINDIA Pharmaceuticals Business Overview Table 90. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio Table 92. VETINDIA Pharmaceuticals Recent Development Table 93. SOUND Technologies Company Information Table 94. SOUND Technologies Business Overview Table 95. SOUND Technologies Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. SOUND Technologies Pet Disease Drugs Product Portfolio Table 97. SOUND Technologies Recent Development Table 98. SeQuent Scientific Company Information Table 99. SeQuent Scientific Business Overview Table 100. SeQuent Scientific Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. SeQuent Scientific Pet Disease Drugs Product Portfolio Table 102. SeQuent Scientific Recent Development Table 103. Richter Pharma Company Information Table 104. Richter Pharma Business Overview Table 105. Richter Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Richter Pharma Pet Disease Drugs Product Portfolio Table 107. Richter Pharma Recent Development Table 108. Ourofino Animal Health Company Information Table 109. Ourofino Animal Health Business Overview Table 110. Ourofino Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Ourofino Animal Health Pet Disease Drugs Product Portfolio Table 112. Ourofino Animal Health Recent Development Table 113. Norbrook Laboratories Company Information Table 114. Norbrook Laboratories Business Overview Table 115. Norbrook Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Norbrook Laboratories Pet Disease Drugs Product Portfolio Table 117. Norbrook Laboratories Recent Development Table 118. Multi Radiance Medical Company Information Table 119. Multi Radiance Medical Business Overview Table 120. Multi Radiance Medical Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Multi Radiance Medical Pet Disease Drugs Product Portfolio Table 122. Multi Radiance Medical Recent Development Table 123. Morvel Laboratories Company Information Table 124. Morvel Laboratories Business Overview Table 125. Morvel Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Morvel Laboratories Pet Disease Drugs Product Portfolio Table 127. Morvel Laboratories Recent Development Table 128. LABINDIA Healthcare Company Information Table 129. LABINDIA Healthcare Business Overview Table 130. LABINDIA Healthcare Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. LABINDIA Healthcare Pet Disease Drugs Product Portfolio Table 132. LABINDIA Healthcare Recent Development Table 133. K-Laser USA Company Information Table 134. K-Laser USA Business Overview Table 135. K-Laser USA Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. K-Laser USA Pet Disease Drugs Product Portfolio Table 137. K-Laser USA Recent Development Table 138. IRM Enterprises Company Information Table 139. IRM Enterprises Business Overview Table 140. IRM Enterprises Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. IRM Enterprises Pet Disease Drugs Product Portfolio Table 142. IRM Enterprises Recent Development Table 143. Fidelis Animal Health Company Information Table 144. Fidelis Animal Health Business Overview Table 145. Fidelis Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Fidelis Animal Health Pet Disease Drugs Product Portfolio Table 147. Fidelis Animal Health Recent Development Table 148. Elanco Animal Health Company Information Table 149. Elanco Animal Health Business Overview Table 150. Elanco Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Elanco Animal Health Pet Disease Drugs Product Portfolio Table 152. Elanco Animal Health Recent Development Table 153. Dechra Pharmaceuticals Company Information Table 154. Dechra Pharmaceuticals Business Overview Table 155. Dechra Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio Table 157. Dechra Pharmaceuticals Recent Development Table 158. Chanelle Pharma Company Information Table 159. Chanelle Pharma Business Overview Table 160. Chanelle Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 161. Chanelle Pharma Pet Disease Drugs Product Portfolio Table 162. Chanelle Pharma Recent Development Table 163. Ceva Company Information Table 164. Ceva Business Overview Table 165. Ceva Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 166. Ceva Pet Disease Drugs Product Portfolio Table 167. Ceva Recent Development Table 168. Century Pharmaceuticals Company Information Table 169. Century Pharmaceuticals Business Overview Table 170. Century Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 171. Century Pharmaceuticals Pet Disease Drugs Product Portfolio Table 172. Century Pharmaceuticals Recent Development Table 173. Calier Company Information Table 174. Calier Business Overview Table 175. Calier Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 176. Calier Pet Disease Drugs Product Portfolio Table 177. Calier Recent Development Table 178. Boehringer Ingelheim Company Information Table 179. Boehringer Ingelheim Business Overview Table 180. Boehringer Ingelheim Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 181. Boehringer Ingelheim Pet Disease Drugs Product Portfolio Table 182. Boehringer Ingelheim Recent Development Table 183. Bimeda Company Information Table 184. Bimeda Business Overview Table 185. Bimeda Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 186. Bimeda Pet Disease Drugs Product Portfolio Table 187. Bimeda Recent Development Table 188. Avazzia Company Information Table 189. Avazzia Business Overview Table 190. Avazzia Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 191. Avazzia Pet Disease Drugs Product Portfolio Table 192. Avazzia Recent Development Table 193. Assisi Animal Health Company Information Table 194. Assisi Animal Health Business Overview Table 195. Assisi Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 196. Assisi Animal Health Pet Disease Drugs Product Portfolio Table 197. Assisi Animal Health Recent Development Table 198. Ashish Life Science Company Information Table 199. Ashish Life Science Business Overview Table 200. Ashish Life Science Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 201. Ashish Life Science Pet Disease Drugs Product Portfolio Table 202. Ashish Life Science Recent Development Table 203. North America Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 204. North America Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 205. North America Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 206. North America Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 207. North America Pet Disease Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 208. North America Pet Disease Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 209. North America Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 210. North America Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 211. North America Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 212. North America Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 213. North America Pet Disease Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 214. North America Pet Disease Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 215. North America Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. North America Pet Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. North America Pet Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. North America Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. North America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 220. North America Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 221. North America Pet Disease Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 222. North America Pet Disease Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 223. United States Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 224. Canada Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 225. Mexico Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 226. Europe Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 227. Europe Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 228. Europe Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 229. Europe Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 230. Europe Pet Disease Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 231. Europe Pet Disease Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 232. Europe Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 233. Europe Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 234. Europe Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 235. Europe Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 236. Europe Pet Disease Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 237. Europe Pet Disease Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 238. Europe Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. Europe Pet Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. Europe Pet Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. Europe Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 242. Europe Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 243. Europe Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 244. Europe Pet Disease Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 245. Europe Pet Disease Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 246. Germany Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 247. France Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 248. U.K. Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 249. Italy Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 250. Russia Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 251. Spain Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 252. Netherlands Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 253. Switzerland Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 254. Sweden Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 255. Poland Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 256. China Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 257. China Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 258. China Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 259. China Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 260. China Pet Disease Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 261. China Pet Disease Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 262. China Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 263. China Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 264. China Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 265. China Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 266. China Pet Disease Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 267. China Pet Disease Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 268. Asia Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 269. Asia Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 270. Asia Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 271. Asia Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 272. Asia Pet Disease Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 273. Asia Pet Disease Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 274. Asia Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 275. Asia Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 276. Asia Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 277. Asia Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 278. Asia Pet Disease Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 279. Asia Pet Disease Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 280. Asia Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 281. Asia Pet Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 282. Asia Pet Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 283. Asia Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 284. Asia Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 285. Asia Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 286. Asia Pet Disease Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 287. Asia Pet Disease Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 288. Japan Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 289. South Korea Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 290. India Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 291. Australia Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 292. Taiwan Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 293. Southeast Asia Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 294. SAMEA Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 295. SAMEA Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 296. SAMEA Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 297. SAMEA Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 298. SAMEA Pet Disease Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 299. SAMEA Pet Disease Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 300. SAMEA Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 301. SAMEA Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 302. SAMEA Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 303. SAMEA Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 304. SAMEA Pet Disease Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 305. SAMEA Pet Disease Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 306. SAMEA Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 307. SAMEA Pet Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 308. SAMEA Pet Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 309. SAMEA Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 310. SAMEA Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 311. SAMEA Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 312. SAMEA Pet Disease Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 313. SAMEA Pet Disease Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 314. Brazil Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 315. Argentina Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 316. Chile Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 317. Colombia Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 318. Peru Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 319. Saudi Arabia Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 320. Israel Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 321. UAE Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 322. Turkey Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 323. Iran Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 324. Egypt Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Table 325. Key Raw Materials Table 326. Raw Materials Key Suppliers Table 327. Pet Disease Drugs Distributors List Table 328. Pet Disease Drugs Customers List Table 329. Research Programs/Design for This Report Table 330. Authors List of This Report Table 331. Secondary Sources Table 332. Primary Sources List of Figures Figure 1. Pet Disease Drugs Image Figure 2. Global Pet Disease Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Analgesics Image Figure 5. Anti-inflammatory Image Figure 6. Parasiticides Image Figure 7. Anti-infectives Image Figure 8. Others Image Figure 9. Global Pet Disease Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Pet Disease Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Behavioral Diseases Image Figure 12. Pain Image Figure 13. Dermatologic Diseases Image Figure 14. Orthopedic Diseases Image Figure 15. Infectious Diseases Image Figure 16. Other Image Figure 17. Global Pet Disease Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global Pet Disease Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pet Disease Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Pet Disease Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global Pet Disease Drugs Sales (2021-2032) & (k units) Figure 23. Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global Pet Disease Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Pet Disease Drugs Sales YoY (2021-2032) & (k units) Figure 26. Europe Pet Disease Drugs Sales YoY (2021-2032) & (k units) Figure 27. China Pet Disease Drugs Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) Pet Disease Drugs Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa Pet Disease Drugs Sales YoY (2021-2032) & (k units) Figure 30. Global Pet Disease Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Pet Disease Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Pet Disease Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pet Disease Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Pet Disease Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global Pet Disease Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Pet Disease Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Pet Disease Drugs Sales Market Share by Type (2021-2032) Figure 39. Global Pet Disease Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Pet Disease Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Pet Disease Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global Pet Disease Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global Pet Disease Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Pet Disease Drugs Sales Market Share by Application (2021-2032) Figure 45. North America Pet Disease Drugs Revenue Share by Type (2021-2032) Figure 46. North America Pet Disease Drugs Sales Share by Type (2021-2032) Figure 47. North America Pet Disease Drugs Revenue Share by Application (2021-2032) Figure 48. North America Pet Disease Drugs Sales Share by Application (2021-2032) Figure 49. North America Pet Disease Drugs Revenue Share by Country (2021-2032) Figure 50. North America Pet Disease Drugs Sales Share by Country (2021-2032) Figure 51. Europe Pet Disease Drugs Revenue Share by Type (2021-2032) Figure 52. Europe Pet Disease Drugs Sales Share by Type (2021-2032) Figure 53. Europe Pet Disease Drugs Revenue Share by Application (2021-2032) Figure 54. Europe Pet Disease Drugs Sales Share by Application (2021-2032) Figure 55. Europe Pet Disease Drugs Revenue Share by Country (2021-2032) Figure 56. Europe Pet Disease Drugs Sales Share by Country (2021-2032) Figure 57. China Pet Disease Drugs Revenue Share by Type (2021-2032) Figure 58. China Pet Disease Drugs Sales Share by Type (2021-2032) Figure 59. China Pet Disease Drugs Revenue Share by Application (2021-2032) Figure 60. China Pet Disease Drugs Sales Share by Application (2021-2032) Figure 61. Asia Pet Disease Drugs Revenue Share by Type (2021-2032) Figure 62. Asia Pet Disease Drugs Sales Share by Type (2021-2032) Figure 63. Asia Pet Disease Drugs Revenue Share by Application (2021-2032) Figure 64. Asia Pet Disease Drugs Sales Share by Application (2021-2032) Figure 65. Asia Pet Disease Drugs Revenue Share by Country (2021-2032) Figure 66. Asia Pet Disease Drugs Sales Share by Country (2021-2032) Figure 67. SAMEA Pet Disease Drugs Revenue Share by Type (2021-2032) Figure 68. SAMEA Pet Disease Drugs Sales Share by Type (2021-2032) Figure 69. SAMEA Pet Disease Drugs Revenue Share by Application (2021-2032) Figure 70. SAMEA Pet Disease Drugs Sales Share by Application (2021-2032) Figure 71. SAMEA Pet Disease Drugs Revenue Share by Country (2021-2032) Figure 72. SAMEA Pet Disease Drugs Sales Share by Country (2021-2032) Figure 73. Pet Disease Drugs Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Pet Disease Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Anti-inflammatory
  • Parasiticides
  • Anti-infectives
  • Others
Applications
  • Behavioral Diseases
  • Pain
  • Dermatologic Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • Other
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Zuche Pharmaceuticals
  • Virbac
  • Vetoquinol S.A.
  • VETINDIA Pharmaceuticals
  • SOUND Technologies
  • SeQuent Scientific
  • Richter Pharma
  • Ourofino Animal Health
  • Norbrook Laboratories
  • Multi Radiance Medical
  • Morvel Laboratories
  • LABINDIA Healthcare
  • K-Laser USA
  • IRM Enterprises
  • Fidelis Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Chanelle Pharma
  • Ceva
  • Century Pharmaceuticals
  • Calier
  • Boehringer Ingelheim
  • Bimeda
  • Avazzia
  • Assisi Animal Health
  • Ashish Life Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Disease Drugs Market by Type
  3. 1.2.1 Global Pet Disease Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Analgesics
  5. 1.2.3 Anti-inflammatory
  6. 1.2.4 Parasiticides
  7. 1.2.5 Anti-infectives
  8. 1.2.6 Others
  9. 1.3 Pet Disease Drugs Market by Application
  10. 1.3.1 Global Pet Disease Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Behavioral Diseases
  12. 1.3.3 Pain
  13. 1.3.4 Dermatologic Diseases
  14. 1.3.5 Orthopedic Diseases
  15. 1.3.6 Infectious Diseases
  16. 1.3.7 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Pet Disease Drugs Market Dynamics
  1. 2.1 Pet Disease Drugs Industry Trends
  2. 2.2 Pet Disease Drugs Industry Drivers
  3. 2.3 Pet Disease Drugs Industry Opportunities and Challenges
  4. 2.4 Pet Disease Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pet Disease Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pet Disease Drugs Revenue by Region
  3. 3.2.1 Global Pet Disease Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Disease Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Pet Disease Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Pet Disease Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pet Disease Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pet Disease Drugs Sales by Region
  9. 3.4.1 Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pet Disease Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Pet Disease Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Pet Disease Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pet Disease Drugs Revenue by Manufacturers
  2. 4.1.1 Global Pet Disease Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pet Disease Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pet Disease Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Disease Drugs Sales by Manufacturers
  6. 4.2.1 Global Pet Disease Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pet Disease Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pet Disease Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pet Disease Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pet Disease Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pet Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pet Disease Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Pet Disease Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pet Disease Drugs Market CR5 and HHI
  16. 4.8.2 2025 Pet Disease Drugs Tier 1, Tier 2, and Tier 3
5 Pet Disease Drugs Market by Type
  1. 5.1 Global Pet Disease Drugs Revenue by Type
  2. 5.1.1 Global Pet Disease Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pet Disease Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pet Disease Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pet Disease Drugs Sales by Type
  6. 5.2.1 Global Pet Disease Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Disease Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pet Disease Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pet Disease Drugs Price by Type
6 Pet Disease Drugs Market by Application
  1. 6.1 Global Pet Disease Drugs Revenue by Application
  2. 6.1.1 Global Pet Disease Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pet Disease Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pet Disease Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pet Disease Drugs Sales by Application
  6. 6.2.1 Global Pet Disease Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pet Disease Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pet Disease Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pet Disease Drugs Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Pet Disease Drugs Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 Zuche Pharmaceuticals
  14. 7.3.1 Zuche Pharmaceuticals Company Information
  15. 7.3.2 Zuche Pharmaceuticals Business Overview
  16. 7.3.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
  18. 7.3.5 Zuche Pharmaceuticals Recent Developments
  19. 7.4 Virbac
  20. 7.4.1 Virbac Company Information
  21. 7.4.2 Virbac Business Overview
  22. 7.4.3 Virbac Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Virbac Pet Disease Drugs Product Portfolio
  24. 7.4.5 Virbac Recent Developments
  25. 7.5 Vetoquinol S.A.
  26. 7.5.1 Vetoquinol S.A. Company Information
  27. 7.5.2 Vetoquinol S.A. Business Overview
  28. 7.5.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
  30. 7.5.5 Vetoquinol S.A. Recent Developments
  31. 7.6 VETINDIA Pharmaceuticals
  32. 7.6.1 VETINDIA Pharmaceuticals Company Information
  33. 7.6.2 VETINDIA Pharmaceuticals Business Overview
  34. 7.6.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
  36. 7.6.5 VETINDIA Pharmaceuticals Recent Developments
  37. 7.7 SOUND Technologies
  38. 7.7.1 SOUND Technologies Company Information
  39. 7.7.2 SOUND Technologies Business Overview
  40. 7.7.3 SOUND Technologies Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SOUND Technologies Pet Disease Drugs Product Portfolio
  42. 7.7.5 SOUND Technologies Recent Developments
  43. 7.8 SeQuent Scientific
  44. 7.8.1 SeQuent Scientific Company Information
  45. 7.8.2 SeQuent Scientific Business Overview
  46. 7.8.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
  48. 7.8.5 SeQuent Scientific Recent Developments
  49. 7.9 Richter Pharma
  50. 7.9.1 Richter Pharma Company Information
  51. 7.9.2 Richter Pharma Business Overview
  52. 7.9.3 Richter Pharma Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Richter Pharma Pet Disease Drugs Product Portfolio
  54. 7.9.5 Richter Pharma Recent Developments
  55. 7.10 Ourofino Animal Health
  56. 7.10.1 Ourofino Animal Health Company Information
  57. 7.10.2 Ourofino Animal Health Business Overview
  58. 7.10.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
  60. 7.10.5 Ourofino Animal Health Recent Developments
  61. 7.11 Norbrook Laboratories
  62. 7.11.1 Norbrook Laboratories Company Information
  63. 7.11.2 Norbrook Laboratories Business Overview
  64. 7.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
  66. 7.11.5 Norbrook Laboratories Recent Developments
  67. 7.12 Multi Radiance Medical
  68. 7.12.1 Multi Radiance Medical Company Information
  69. 7.12.2 Multi Radiance Medical Business Overview
  70. 7.12.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
  72. 7.12.5 Multi Radiance Medical Recent Developments
  73. 7.13 Morvel Laboratories
  74. 7.13.1 Morvel Laboratories Company Information
  75. 7.13.2 Morvel Laboratories Business Overview
  76. 7.13.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
  78. 7.13.5 Morvel Laboratories Recent Developments
  79. 7.14 LABINDIA Healthcare
  80. 7.14.1 LABINDIA Healthcare Company Information
  81. 7.14.2 LABINDIA Healthcare Business Overview
  82. 7.14.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
  84. 7.14.5 LABINDIA Healthcare Recent Developments
  85. 7.15 K-Laser USA
  86. 7.15.1 K-Laser USA Company Information
  87. 7.15.2 K-Laser USA Business Overview
  88. 7.15.3 K-Laser USA Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 K-Laser USA Pet Disease Drugs Product Portfolio
  90. 7.15.5 K-Laser USA Recent Developments
  91. 7.16 IRM Enterprises
  92. 7.16.1 IRM Enterprises Company Information
  93. 7.16.2 IRM Enterprises Business Overview
  94. 7.16.3 IRM Enterprises Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 IRM Enterprises Pet Disease Drugs Product Portfolio
  96. 7.16.5 IRM Enterprises Recent Developments
  97. 7.17 Fidelis Animal Health
  98. 7.17.1 Fidelis Animal Health Company Information
  99. 7.17.2 Fidelis Animal Health Business Overview
  100. 7.17.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
  102. 7.17.5 Fidelis Animal Health Recent Developments
  103. 7.18 Elanco Animal Health
  104. 7.18.1 Elanco Animal Health Company Information
  105. 7.18.2 Elanco Animal Health Business Overview
  106. 7.18.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
  108. 7.18.5 Elanco Animal Health Recent Developments
  109. 7.19 Dechra Pharmaceuticals
  110. 7.19.1 Dechra Pharmaceuticals Company Information
  111. 7.19.2 Dechra Pharmaceuticals Business Overview
  112. 7.19.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
  114. 7.19.5 Dechra Pharmaceuticals Recent Developments
  115. 7.20 Chanelle Pharma
  116. 7.20.1 Chanelle Pharma Company Information
  117. 7.20.2 Chanelle Pharma Business Overview
  118. 7.20.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
  120. 7.20.5 Chanelle Pharma Recent Developments
  121. 7.21 Ceva
  122. 7.21.1 Ceva Company Information
  123. 7.21.2 Ceva Business Overview
  124. 7.21.3 Ceva Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Ceva Pet Disease Drugs Product Portfolio
  126. 7.21.5 Ceva Recent Developments
  127. 7.22 Century Pharmaceuticals
  128. 7.22.1 Century Pharmaceuticals Company Information
  129. 7.22.2 Century Pharmaceuticals Business Overview
  130. 7.22.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
  132. 7.22.5 Century Pharmaceuticals Recent Developments
  133. 7.23 Calier
  134. 7.23.1 Calier Company Information
  135. 7.23.2 Calier Business Overview
  136. 7.23.3 Calier Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Calier Pet Disease Drugs Product Portfolio
  138. 7.23.5 Calier Recent Developments
  139. 7.24 Boehringer Ingelheim
  140. 7.24.1 Boehringer Ingelheim Company Information
  141. 7.24.2 Boehringer Ingelheim Business Overview
  142. 7.24.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
  144. 7.24.5 Boehringer Ingelheim Recent Developments
  145. 7.25 Bimeda
  146. 7.25.1 Bimeda Company Information
  147. 7.25.2 Bimeda Business Overview
  148. 7.25.3 Bimeda Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Bimeda Pet Disease Drugs Product Portfolio
  150. 7.25.5 Bimeda Recent Developments
  151. 7.26 Avazzia
  152. 7.26.1 Avazzia Company Information
  153. 7.26.2 Avazzia Business Overview
  154. 7.26.3 Avazzia Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Avazzia Pet Disease Drugs Product Portfolio
  156. 7.26.5 Avazzia Recent Developments
  157. 7.27 Assisi Animal Health
  158. 7.27.1 Assisi Animal Health Company Information
  159. 7.27.2 Assisi Animal Health Business Overview
  160. 7.27.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
  162. 7.27.5 Assisi Animal Health Recent Developments
  163. 7.28 Ashish Life Science
  164. 7.28.1 Ashish Life Science Company Information
  165. 7.28.2 Ashish Life Science Business Overview
  166. 7.28.3 Ashish Life Science Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Ashish Life Science Pet Disease Drugs Product Portfolio
  168. 7.28.5 Ashish Life Science Recent Developments
8 North America
  1. 8.1 North America Pet Disease Drugs Market Size by Type
  2. 8.1.1 North America Pet Disease Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Pet Disease Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Pet Disease Drugs Price by Type (2021-2032)
  5. 8.2 North America Pet Disease Drugs Market Size by Application
  6. 8.2.1 North America Pet Disease Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Pet Disease Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Pet Disease Drugs Price by Application (2021-2032)
  9. 8.3 North America Pet Disease Drugs Market Size by Country
  10. 8.3.1 North America Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pet Disease Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pet Disease Drugs Market Size by Type
  2. 9.1.1 Europe Pet Disease Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pet Disease Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Pet Disease Drugs Price by Type (2021-2032)
  5. 9.2 Europe Pet Disease Drugs Market Size by Application
  6. 9.2.1 Europe Pet Disease Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pet Disease Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Pet Disease Drugs Price by Application (2021-2032)
  9. 9.3 Europe Pet Disease Drugs Market Size by Country
  10. 9.3.1 Europe Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pet Disease Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pet Disease Drugs Market Size by Type
  2. 10.1.1 China Pet Disease Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Pet Disease Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Pet Disease Drugs Price by Type (2021-2032)
  5. 10.2 China Pet Disease Drugs Market Size by Application
  6. 10.2.1 China Pet Disease Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Pet Disease Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Pet Disease Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Disease Drugs Market Size by Type
  2. 11.1.1 Asia Pet Disease Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pet Disease Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Pet Disease Drugs Price by Type (2021-2032)
  5. 11.2 Asia Pet Disease Drugs Market Size by Application
  6. 11.2.1 Asia Pet Disease Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pet Disease Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Pet Disease Drugs Price by Application (2021-2032)
  9. 11.3 Asia Pet Disease Drugs Market Size by Country
  10. 11.3.1 Asia Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pet Disease Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Disease Drugs Market Size by Type
  2. 12.1.1 SAMEA Pet Disease Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pet Disease Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pet Disease Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Pet Disease Drugs Market Size by Application
  6. 12.2.1 SAMEA Pet Disease Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pet Disease Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pet Disease Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Pet Disease Drugs Market Size by Country
  10. 12.3.1 SAMEA Pet Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pet Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pet Disease Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pet Disease Drugs Value Chain Analysis
  2. 13.1.1 Pet Disease Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pet Disease Drugs Production Mode & Process
  6. 13.2 Pet Disease Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pet Disease Drugs Distributors
  9. 13.2.3 Pet Disease Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst